Marc Sanson

6PUBLICATIONS
76CO-AUTHORS
Gene and molecular therapyCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 02, 2026
18F-DOPA-PET and Advanced MRI Improve Treatment Response Assessment in IDH1/2-Mutant Gliomas Treated with IDH Inhibitors.

Diego Prost, Lucia Nichelli, Laura Rozenblum

|Aug 19, 2025
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Patrick Y Wen, Michael Weller, Eudocia Q Lee

|Oct 10, 2024
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1.

Martin J van den Bent, Enrico Franceschi, Mehdi Touat

|Nov 29, 2022
LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL.

Aram Ko, Mohammad Hasanain, Young Taek Oh

|Mar 11, 2022
Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial.

C Mircea S Tesileanu, Marc Sanson, Wolfgang Wick

|Nov 02, 2019
Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas.

Elena Trisolini, Dounia El Wardighi, Marine Giry

Pageof 1

Frequent Collaborators

3 joint publications

Mehdi Touat

3 joint publications

Franck Bielle

3 joint publications

Michael Weller

3 joint publications

Pim J French